Urological cancer, Malmö
41 – 50 of 560
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer : A Subgroup Analysis of TITAN
- Contribution to journal › Article
-
Mark
Reply to Natália Dalsenter Avilez, Tomás Bernardo Costa Moretti, and Leonardo Oliveira Reis' Letter to the Editor re : Anna Lantz, Ying Li, Stefan Carlsson, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.004
- Contribution to journal › Article
-
Mark
Dietary Patterns in Prostate Cancer Prevention and Management : A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials
- Contribution to journal › Scientific review
-
Mark
SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
(2025) In European Urology
- Contribution to journal › Article
-
Mark
Adverse events during radical prostatectomy and their association with recurrence and death
- Contribution to journal › Article
-
Mark
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer
- Contribution to journal › Article
-
Mark
Diagnosis and Initial Management of Renal Cell Carcinoma
(2025) p.273-288
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
- Contribution to journal › Article
-
Mark
Fosfomycin versus ciprofloxacin for transrectal prostate biopsy : An open randomised controlled multicentre drug trial
(2025) In Journal of Clinical Urology
- Contribution to journal › Article
- 2024
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
- Contribution to journal › Article
